vs
C.H. Robinson(CHRW)とTENET HEALTHCARE CORP(THC)の財務データ比較。上の社名をクリックして会社を切り替えられます
TENET HEALTHCARE CORPの直近四半期売上が大きい($5.5B vs $4.0B、C.H. Robinsonの約1.4倍)。TENET HEALTHCARE CORPの純利益率が高く(11.7% vs 3.7%、差は8.0%)。TENET HEALTHCARE CORPの前年同期比売上増加率が高い(9.0% vs -0.8%)。過去8四半期でTENET HEALTHCARE CORPの売上複合成長率が高い(1.5% vs -5.4%)
C.H. Robinsonワールドワイドは米国発の輸送企業で、サードパーティーロジスティクス(3PL)事業を展開しています。貨物輸送・輸送管理・ブローカー業務・倉庫保管に対応し、満載トラック・小口トラック・航空貨物・複合輸送・海上輸送など多様な輸送手段を提供しています。
テネット・ヘルスケア・コーポレーションは米国ダラスに本社を置く営利目的の多国籍医療サービス企業です。USPIをはじめとするブランド・子会社・合弁事業・提携先を通じ、65の病院と450以上の医療施設を運営するほか、Conifer Health Solutionsで医療システムなどの顧客向けに医療支援サービスを提供しています
CHRW vs THC — 直接比較
損益計算書 — Q1 FY2026 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $4.0B | $5.5B |
| 純利益 | $147.2M | $644.0M |
| 粗利率 | 16.1% | — |
| 営業利益率 | 3.6% | 15.4% |
| 純利益率 | 3.7% | 11.7% |
| 売上前年比 | -0.8% | 9.0% |
| 純利益前年比 | — | 12.6% |
| EPS(希薄化後) | — | $4.22 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $4.0B | — | ||
| Q4 25 | $3.9B | $5.5B | ||
| Q3 25 | $4.1B | $5.3B | ||
| Q2 25 | $4.1B | $5.3B | ||
| Q1 25 | $4.0B | $5.2B | ||
| Q4 24 | $4.2B | $5.1B | ||
| Q3 24 | $4.6B | $5.1B | ||
| Q2 24 | $4.5B | $5.1B |
| Q1 26 | $147.2M | — | ||
| Q4 25 | $136.3M | $644.0M | ||
| Q3 25 | $163.0M | $579.0M | ||
| Q2 25 | $152.5M | $522.0M | ||
| Q1 25 | $135.3M | $622.0M | ||
| Q4 24 | $149.3M | $572.0M | ||
| Q3 24 | $97.2M | $681.0M | ||
| Q2 24 | $126.3M | $477.0M |
| Q1 26 | 16.1% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | 3.6% | — | ||
| Q4 25 | 4.6% | 15.4% | ||
| Q3 25 | 5.3% | 16.8% | ||
| Q2 25 | 5.2% | 15.6% | ||
| Q1 25 | 4.4% | 18.1% | ||
| Q4 24 | 4.4% | 16.2% | ||
| Q3 24 | 3.9% | 21.3% | ||
| Q2 24 | 4.0% | 14.9% |
| Q1 26 | 3.7% | — | ||
| Q4 25 | 3.5% | 11.7% | ||
| Q3 25 | 3.9% | 10.9% | ||
| Q2 25 | 3.7% | 9.9% | ||
| Q1 25 | 3.3% | 11.9% | ||
| Q4 24 | 3.6% | 11.3% | ||
| Q3 24 | 2.1% | 13.3% | ||
| Q2 24 | 2.8% | 9.3% |
| Q1 26 | — | — | ||
| Q4 25 | $1.12 | $4.22 | ||
| Q3 25 | $1.34 | $3.86 | ||
| Q2 25 | $1.26 | $3.14 | ||
| Q1 25 | $1.11 | $4.27 | ||
| Q4 24 | $1.23 | $3.79 | ||
| Q3 24 | $0.80 | $4.89 | ||
| Q2 24 | $1.05 | $2.64 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $159.7M | $2.9B |
| 総負債低いほど良い | $1.3B | $13.1B |
| 株主資本純資産 | — | $4.2B |
| 総資産 | $5.2B | $29.7B |
| 負債/資本比率低いほどレバレッジが低い | — | 3.10× |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $159.7M | — | ||
| Q4 25 | $160.9M | $2.9B | ||
| Q3 25 | $136.8M | $3.0B | ||
| Q2 25 | $156.0M | $2.6B | ||
| Q1 25 | $129.9M | $3.0B | ||
| Q4 24 | $145.8M | $3.0B | ||
| Q3 24 | $131.7M | $4.1B | ||
| Q2 24 | $113.2M | $2.9B |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.1B | $13.1B | ||
| Q3 25 | $1.2B | $13.1B | ||
| Q2 25 | $1.4B | $13.1B | ||
| Q1 25 | $1.4B | $13.1B | ||
| Q4 24 | $1.4B | $13.1B | ||
| Q3 24 | $1.6B | $12.8B | ||
| Q2 24 | $1.6B | $12.8B |
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | $4.2B | ||
| Q3 25 | $1.9B | $4.0B | ||
| Q2 25 | $1.8B | $3.7B | ||
| Q1 25 | $1.7B | $4.2B | ||
| Q4 24 | $1.7B | $4.2B | ||
| Q3 24 | $1.6B | $3.8B | ||
| Q2 24 | $1.5B | $3.5B |
| Q1 26 | $5.2B | — | ||
| Q4 25 | $5.1B | $29.7B | ||
| Q3 25 | $5.2B | $29.4B | ||
| Q2 25 | $5.3B | $28.7B | ||
| Q1 25 | $5.2B | $29.2B | ||
| Q4 24 | $5.3B | $28.9B | ||
| Q3 24 | $5.6B | $29.4B | ||
| Q2 24 | $5.5B | $29.3B |
| Q1 26 | — | — | ||
| Q4 25 | 0.59× | 3.10× | ||
| Q3 25 | 0.64× | 3.26× | ||
| Q2 25 | 0.76× | 3.49× | ||
| Q1 25 | 0.80× | 3.13× | ||
| Q4 24 | 0.80× | 3.14× | ||
| Q3 24 | 0.95× | 3.33× | ||
| Q2 24 | 1.07× | 3.67× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $68.6M | $731.0M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $367.0M |
| FCFマージンFCF / 売上 | — | 6.6% |
| 設備投資強度設備投資 / 売上 | — | 6.6% |
| キャッシュ転換率営業CF / 純利益 | 0.47× | 1.14× |
| 直近12ヶ月FCF直近4四半期 | — | $2.5B |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $68.6M | — | ||
| Q4 25 | $305.4M | $731.0M | ||
| Q3 25 | $275.4M | $1.1B | ||
| Q2 25 | $227.1M | $936.0M | ||
| Q1 25 | $106.5M | $815.0M | ||
| Q4 24 | $267.9M | $-331.0M | ||
| Q3 24 | $108.1M | $1.0B | ||
| Q2 24 | $166.4M | $747.0M |
| Q1 26 | — | — | ||
| Q4 25 | $302.4M | $367.0M | ||
| Q3 25 | $269.5M | $778.0M | ||
| Q2 25 | $219.8M | $743.0M | ||
| Q1 25 | $103.2M | $642.0M | ||
| Q4 24 | $265.3M | $-661.0M | ||
| Q3 24 | $103.3M | $829.0M | ||
| Q2 24 | $159.8M | $602.0M |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | 6.6% | ||
| Q3 25 | 6.5% | 14.7% | ||
| Q2 25 | 5.3% | 14.1% | ||
| Q1 25 | 2.5% | 12.3% | ||
| Q4 24 | 6.3% | -13.0% | ||
| Q3 24 | 2.2% | 16.2% | ||
| Q2 24 | 3.6% | 11.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 6.6% | ||
| Q3 25 | 0.1% | 5.3% | ||
| Q2 25 | 0.2% | 3.7% | ||
| Q1 25 | 0.1% | 3.3% | ||
| Q4 24 | 0.1% | 6.5% | ||
| Q3 24 | 0.1% | 4.2% | ||
| Q2 24 | 0.1% | 2.8% |
| Q1 26 | 0.47× | — | ||
| Q4 25 | 2.24× | 1.14× | ||
| Q3 25 | 1.69× | 1.83× | ||
| Q2 25 | 1.49× | 1.79× | ||
| Q1 25 | 0.79× | 1.31× | ||
| Q4 24 | 1.79× | -0.58× | ||
| Q3 24 | 1.11× | 1.53× | ||
| Q2 24 | 1.32× | 1.57× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CHRW
| Transportation | $3.6B | 91% |
| Sourcing | $369.2M | 9% |
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |